SPDEF Knockout HEC-1-B Cell Line
Cat.No.:
EDC07683
Species:
Human
Cell Name:
HEC-1-B
Gene:
SPDEF
Gene ID:
25803
Size:
1×10⁶cells
SPDEF Knockout HEC-1-B Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07683 |
|---|---|
| Product Name | SPDEF Knockout HEC-1-B Cell Line |
| Species | Human |
| Cell Line | HEC-1-B |
| Cellosaurus ID | CVCL_0294 |
| Gene ID | |
| Cell Line Synonyms | Hec-1-B, HEC-1B, Hec-1b, HEC1-B, HEC1B, Hec1B |
| Gene | SPDEF |
| Summary |
The protein encoded by this gene belongs to the ETS family of transcription factors. It is highly expressed in the prostate epithelial cells, and functions as an androgen-independent transactivator of prostate-specific antigen (PSA) promoter. Higher expression of this protein has also been reported in brain, breast, lung and ovarian tumors, compared to the corresponding normal tissues, and it shows better tumor-association than other cancer-associated molecules, making it a more suitable target for developing specific cancer therapies. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
|
| Digestion Time | 5 min |
| Associated Diseases | Endometrial Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:2 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 92% complete culture medium+8% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEC-1-B | STR Info (Cell bank) Cell Line: HEC-1-B | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| CSF1PO | 10 | 12 | 10 | 12 |
| D5S818 | 11 | 13 | 11 | 13 |
| D7S820 | 9 | 11 | 9 | 11 |
| D13S317 | 11 | 16 | 11 | 16 |
| D16S539 | 11 | 12 | 11 | 12 |
| TH01 | 6 | 7 | 6 | 7 |
| TPOX | 8 | 11 | 8 | 11 |
| VWA | 18 | 18 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SPDEF function, SPDEF Knockout HEC-1-B Cell Line or SPDEF overexpression HEC-1-B Cell Line?
The choice depends on whether you are studying SPDEF's role as an ETS family transcription factor in goblet cell differentiation, secretory epithelium biology, or endometrial cancer. The Knockout line is appropriate for asking whether SPDEF is required for mucin gene expression and secretory cell programs — particularly relevant in HEC-1-B, an endometrial adenocarcinoma line where SPDEF has been implicated in disease progression. Overexpression is useful for studying SPDEF's pioneer transcription factor activity or for testing sufficiency for goblet cell-like differentiation.
For SPDEF research, the EDITGENE Knockout in HEC-1-B is particularly relevant for endometrial cancer biology — HEC-1-B is one of the standard endometrial adenocarcinoma models, and SPDEF expression is a feature of this lineage. Rescue with wild-type or DNA-binding-deficient (ETS domain mutant) SPDEF enables structure-function dissection.
What are the application scenarios for this model?
Primary applications:
• Mucin gene expression: MUC5AC, MUC5B, and other secretory cell marker expression analysis following SPDEF loss in the endometrial cancer context.
• Endometrial cancer phenotype: proliferation, migration, and invasion assays relevant to SPDEF's reported roles in endometrial cancer progression.
• Pioneer factor activity: ChIP-seq for SPDEF chromatin occupancy and chromatin accessibility analysis at SPDEF target sites.
• Transcriptomic profiling: RNA-seq to map SPDEF-dependent gene programs in endometrial carcinoma.
EDITGENE recommends this model for researchers investigating SPDEF transcription factor biology, endometrial cancer mechanisms, and ETS family pioneer factor function.
Is this SPDEF Knockout HEC-1-B Cell Line compatible with overexpression rescue experiments?
Yes. SPDEF rescue experiments require attention to ETS family transcription factor function:
• Construct design: use a codon-modified SPDEF sequence with a small C-terminal tag (FLAG, HA). SPDEF contains an N-terminal SAM/PNT domain and C-terminal ETS DNA-binding domain — both should be preserved.
• DNA-binding-deficient rescue: specific point mutations in the ETS DNA-binding domain abolish target site engagement while preserving protein-protein interactions, enabling structure-function dissection.
• SAM/PNT-mutant rescue: SAM/PNT domain mutations affect SPDEF self-association and protein interactions, separating transcriptional activation from polymerization functions.
• Functional readout: rescue should restore mucin gene expression (MUC5AC, MUC5B) and endometrial cancer-related phenotypes in HEC-1-B.
HEC-1-B is an endometrial adenocarcinoma cell line that transduces with lentivirus at standard efficiency and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download